ReviewCardiovascular drugs and therapy2026

Improving the Cardiorenal Usability of Endothelin Receptor Antagonism in Albuminuric Chronic Kidney Disease: A Testable Role for SGLT2 Inhibitor-based Mitigation of Fluid Retention.

Lucas Maciel de Almeida Corrêa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.